Table 2.
Lean (n = 12) | Centrally Obese (n = 12) | P-value | |||||
---|---|---|---|---|---|---|---|
WP | PLA | WP | PLA | Treatment | Condition | Treatment*Condition | |
Glucose AUC (mmol/L/min−1) a | |||||||
0–60 min | 3.8 ± 0.5 | 4.7 ± 0.7* | 4.6 ± 0.4# | 5.3 ± 0.6*# | P <0.0001 | P = 0.002 | P = 0.468 |
0–240 min | 3.9 ± 0.4 | 4.0 ± 0.4 | 4.4 ± 0.3# | 4.5 ± 0.3# | P = 0.055 | P <0.0001 | P = 0.715 |
Insulin iAUC (pmol/L/min−1) a | |||||||
0–60 min | 97.0 ± 59.4 | 102.4 ± 59.9 | 361.8 ± 226.4# | 311.1 ± 215.5# | P = 0.440 | P <0.0001 | P = 0.353 |
0–240 min | 35.1 ± 20.0 | 30.81 ± 18.1 | 139.5 ± 90.2# | 83.3 ± 54.6*# | P = 0.047 | P <0.0001 | P = 0.379 |
GLP-1 iAUC (pmol/L/min−1) a | |||||||
0–60 min | 23.6 ± 7.4 | 7.3 ± 5.0* | 19.4 ± 7.9 | 6.7 ± 4.0* | P <0.0001 | P = 0.217 | P = 0.181 |
0–240 min | 15.0 ± 4.3 | 4.7 ± 3.7* | 11.8 ± 4.6# | 5.2 ± 4.1* | P = 0.001 | P = 0.040 | P = 0.011 |
GLP-1ACTIVE iAUC (pmol/L/min−1) a | |||||||
0–60 min | 3.8 ± 1.9 | 1.5 ± 1.1* | 2.3 ± 1.4 | 1.1 ± 0.6* | P <0.0001 | P = 0.196 | P = 0.217 |
0–240 min | 2.0 ± 0.7 | 0.7 ± 0.4* | 1.4 ± 0.7 | 0.8 ± 0.5* | P <0.0001 | P=0.426 | P = 0.043 |
GLP-1ACTIVE/TOTAL iAUC (pmol/L × min−1) b | |||||||
0–60 min | 4.7 ± 2.6 | 2.5 ± 1.7* | 2.4 ± 1.7# | 1.9 ± 1.4 | P = 0.009 | P=0.021 | P = 0.099 |
0–240 min | 10.2 ± 6.4 | 5.2 ± 3.6* | 7.1 ± 3.8 | 5.4 ± 4.7 | P = 0.004 | P = 0.386 | P = 0.132 |
GIP iAUC (pmol/L/min−1) a | |||||||
0–60 min | 50.5 ± 19.0 | 51.8 ± 16.2 | 57.9 ± 23.0 | 53.9 ± 23.2 | P = 0.650 | P = 0.549 | P = 0.383 |
0–240 min | 36.5 ± 14.8 | 31.2 ± 13.7 | 43.3 ± 14.9 | 33.8 ± 13.7* | P <0.0001 | P = 0.382 | P = 0.247 |
Acetaminophen AUC (mol/L/min-1) a | |||||||
0-60min | 65.1 ± 32.5 | 100.7 ± 31.1* | 58.1 ± 19.7 | 90.0 ± 20.3* | P <0.0001 | P = 0.307 | P = 0.787 |
0-240min | 68.8 ± 14.9 | 77.5 ± 17.5 | 60.3 ± 13.1 | 67.2 ± 11.4 | P = 0.029 | P = 0.067 | P = 0.793 |
Data presented as means ± SD.
Variables are presented as time-averaged during the early (0 -60 min) and total (0–240 min) postprandial period.
The iAUC for GLP-1ACTIVE/TOTAL is presented as the as the sum of iAUC over time (i.e., 60 or 240 min) and is thus, not time-averaged.
All data were analysed by a two-way mixed ANOVA. Between and within group differences were analysed if there were any significant main or interaction effects reported from the ANOVA.
*Denotes a within-group treatment effect (WP vs PLA).
#Denotes a between-group effect (lean vs centrally obese).
Bold values indicate statistical significance from the two-way mixed ANOVA.